End-of-day quote
Shenzhen S.E.
23:00:00 29/04/2024 BST
|
5-day change
|
1st Jan Change
|
14.64
CNY
|
-6.69%
|
|
-7.11%
|
-2.47%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,492
|
19,390
|
15,577
|
9,652
|
8,634
|
8,421
|
-
|
-
|
Enterprise Value (EV)
1 |
10,492
|
19,390
|
15,577
|
9,652
|
8,634
|
8,421
|
8,421
|
8,421
|
P/E ratio
|
48.1
x
|
83.3
x
|
82.1
x
|
52.4
x
|
42.9
x
|
28.2
x
|
20.2
x
|
19.1
x
|
Yield
|
-
|
-
|
0.55%
|
0.89%
|
1%
|
1.5%
|
2.53%
|
-
|
Capitalization / Revenue
|
6.61
x
|
10.5
x
|
6.93
x
|
3.71
x
|
2.99
x
|
2.58
x
|
2.11
x
|
2.02
x
|
EV / Revenue
|
6.61
x
|
10.5
x
|
6.93
x
|
3.71
x
|
2.99
x
|
2.58
x
|
2.11
x
|
2.02
x
|
EV / EBITDA
|
31.6
x
|
39.6
x
|
-
|
14.6
x
|
16.3
x
|
12.7
x
|
10.2
x
|
8.66
x
|
EV / FCF
|
-
|
-
|
357
x
|
-174
x
|
160
x
|
-90.6
x
|
196
x
|
-
|
FCF Yield
|
-
|
-
|
0.28%
|
-0.57%
|
0.62%
|
-1.1%
|
0.51%
|
-
|
Price to Book
|
6.87
x
|
11.3
x
|
4.57
x
|
2.76
x
|
2.4
x
|
2.21
x
|
2
x
|
1.92
x
|
Nbr of stocks (in thousands)
|
529,072
|
529,072
|
575,226
|
575,226
|
575,226
|
575,226
|
-
|
-
|
Reference price
2 |
19.83
|
36.65
|
27.08
|
16.78
|
15.01
|
14.64
|
14.64
|
14.64
|
Announcement Date
|
26/02/20
|
30/03/21
|
30/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,588
|
1,840
|
2,247
|
2,604
|
2,889
|
3,262
|
3,983
|
4,160
|
EBITDA
1 |
332.3
|
490.1
|
-
|
658.9
|
529.1
|
663.9
|
825.8
|
972.5
|
EBIT
1 |
173.8
|
232.1
|
201
|
181.2
|
199.9
|
307.5
|
429.6
|
452.4
|
Operating Margin
|
10.94%
|
12.61%
|
8.95%
|
6.96%
|
6.92%
|
9.43%
|
10.79%
|
10.88%
|
Earnings before Tax (EBT)
1 |
176.4
|
246.1
|
204.5
|
184.1
|
207.7
|
313.9
|
434.8
|
458.8
|
Net income
1 |
169.4
|
235.4
|
182.2
|
184
|
199.4
|
299.8
|
416.7
|
439.5
|
Net margin
|
10.67%
|
12.79%
|
8.11%
|
7.06%
|
6.9%
|
9.19%
|
10.46%
|
10.56%
|
EPS
2 |
0.4125
|
0.4400
|
0.3300
|
0.3200
|
0.3500
|
0.5200
|
0.7233
|
0.7650
|
Free Cash Flow
1 |
-
|
-
|
43.65
|
-55.47
|
53.87
|
-93
|
43
|
-
|
FCF margin
|
-
|
-
|
1.94%
|
-2.13%
|
1.86%
|
-2.85%
|
1.08%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
10.18%
|
-
|
5.21%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
23.96%
|
-
|
27.02%
|
-
|
10.32%
|
-
|
Dividend per Share
2 |
-
|
-
|
0.1500
|
0.1500
|
0.1500
|
0.2200
|
0.3700
|
-
|
Announcement Date
|
26/02/20
|
30/03/21
|
30/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
-79.48
|
Net margin
|
-
|
EPS
|
-
|
Dividend per Share
|
-
|
Announcement Date
|
27/04/22
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
43.7
|
-55.5
|
53.9
|
-93
|
43
|
-
|
ROE (net income / shareholders' equity)
|
18.4%
|
14.6%
|
6.81%
|
5.34%
|
5.65%
|
7.91%
|
9.79%
|
10.1%
|
ROA (Net income/ Total Assets)
|
-
|
7.53%
|
4.22%
|
-
|
3.28%
|
4.71%
|
5.32%
|
5.65%
|
Assets
1 |
-
|
3,126
|
4,313
|
-
|
6,071
|
6,365
|
7,833
|
7,778
|
Book Value Per Share
2 |
2.890
|
3.240
|
5.930
|
6.070
|
6.250
|
6.620
|
7.300
|
7.620
|
Cash Flow per Share
2 |
0.3200
|
0.7900
|
0.9000
|
0.9500
|
1.130
|
1.230
|
1.300
|
1.500
|
Capex
1 |
422
|
363
|
455
|
604
|
594
|
389
|
534
|
413
|
Capex / Sales
|
26.57%
|
19.71%
|
20.25%
|
23.2%
|
20.55%
|
11.94%
|
13.4%
|
9.94%
|
Announcement Date
|
26/02/20
|
30/03/21
|
30/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Last Close Price
14.64
CNY Average target price
18.22
CNY Spread / Average Target +24.45% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.47% | 1.16B | | 0.00% | 7.08B | | -11.41% | 2.91B | | -6.89% | 2.85B | | -27.64% | 1.83B | | -6.63% | 1.07B | | -10.95% | 831M | | +0.83% | 767M | | -9.85% | 747M | | -19.31% | 719M |
Testing Laboratories
|